المؤلفون: Eustaquio Maria Onorato, Francesco Alamanni, Manuela Muratori, Grzegorz Smolka, Wojtek Wojakowski, Piotr Pysz, Aleksejus Zorinas, Diana Zakarkaite, Hélène Eltchaninoff, Pierre-Yves Litzer, François Godart, Patrick Calvert, Christos Christou, Abdurashid Mussayev, Bindo Missiroli, Igor Buzaev, Salvatore Curello, Tullio Tesorio, Antonio Luca Bartorelli

المصدر: Journal of Clinical Medicine, Vol 11, Iss 7, p 1978 (2022)

مصطلحات موضوعية: paravalvular leak, paravalvular regurgitation, aortic valve, mitral valve, transcatheter closure, long-term outcomes, Medicine

وصف الملف: electronic resource

العلاقة: https://www.mdpi.com/2077-0383/11/7/1978Test; https://doaj.org/toc/2077-0383Test

الوصول الحر: https://doaj.org/article/9d1c153280b74a84bbd601f3d30ae8dcTest

المؤلفون: Naufal Zagidullin, Lukas Fiedler, Diana Gareeva, Peter Jirak, Paruir Davtyan, Michael Lichtenauer, Irina Lakman, Gulnaz Lasynova, Igor Buzaev, Uta C. Hoppe, Kristen Kopp, Rudin Pistulli, Moritz Mirna, Valentin Pavlov, Lukas Jaroslaw Motloch, Anna Dieplinger

المصدر: Journal of the American College of Cardiology. 81:2118

مصطلحات موضوعية: Cardiology and Cardiovascular Medicine

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::152fb5693eca0d372412314894e9685aTest
https://doi.org/10.1016/s0735-1097Test(23)02562-7

المؤلفون: Irina Mustafina, Naufal Zagidullin, Igor Buzaev, Valentin Pavlov

المصدر: Journal of the American College of Cardiology. 81:1695

مصطلحات موضوعية: Cardiology and Cardiovascular Medicine

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::283ae3bdb7695e2248f600cfcadaf58cTest
https://doi.org/10.1016/s0735-1097Test(23)02139-3

المؤلفون: Vladimir Plechev, Irina Nikolaeva N., Igor Buzaev V., Ilgiz Zagitov G., Roman Rizberg Yu., Inna Yamanaeva E., В. Плечев В., И. Николаева Е., И. Бузаев В., И. Загитов Г., Р. Ризберг Ю., И. Яманаева Е.

المصدر: Creative surgery and oncology; Том 7, № 4 (2017); 53-62 ; Креативная хирургия и онкология; Том 7, № 4 (2017); 53-62 ; 2076-3093 ; 2307-0501 ; 10.24060/2076-3093-2017-7-4

مصطلحات موضوعية: absorb, scaffold bioresorbable intravascular scaffolds, percutaneous coronary intervention, stent, stenting, absorbable stents, coronary heart disease, абсорб, скафолд, биорезорбируемые внутрисосудистые каркасы, чрескожное коронарное вмешательство, стенты, стентирование, ишемическая болезнь сердца

وصف الملف: application/pdf

العلاقة: https://www.surgonco.ru/jour/article/view/271/256Test; Serruys P.W, Garcia-Garcia H.M, Onuma Y. From metallic cages to transient bioresorbable scaffolds: Change in paradigm of coronary revascularization in the upcoming decade? Eur Heart J. 2012;33 (1):16-25. DOI:10.1093/eurheartj/ehr384.; Ormiston J.A, Serruys P.W.S. Bioabsorbable coronary stents. Circ Cardiovasc Interv. 2009;2(3): 255– 60. DOI:10.1161/CIRCINTERVENTIONS.109.859173.; Sigwart U., Puel J., Mirkovitch V., Joffre F., Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med. 1987;316(12):701–6. DOI:10.1056/NEJM198703193161201.; Rensing B.J, Vos J., Smits P.C, Foley D.P, Van Den Brand M.J.B.M, Van Der Giessen W.J., et al. Coronary restenosis elimination with a sirolimus eluting stent: First European human experience with 6-month angiographic and intravascular ultrasonic followup. Eur Heart J. 2001;22(22):2125–30. DOI:10.1053/euhj.2001.2892; Radu M.D. The Clinical Atlas of Intravascular Optical Coherence Tomography (OCT) for iPad. Eur Heart J. 2012;33(10):1174-5. DOI:10.1093/eurheartj/ehs102.; Ramcharitar S., Garcia-Garcia H.M., Nakazawa G., Kukreja N., Ligthart J., Virmani R., et al. Ultrasonic and pathological evidence of a neo-intimal plaque rupture in patients with bare metal stents. EuroIntervention. 2007;3(2):290-1. PMID: 19758954.; Nakazawa G., Otsuka F., Nakano M., Vorpahl M., Yazdani S.K., Ladich E., et al. The pathology of neoatherosclerosis in human coronary implants baremetal and drug-eluting stents. J Am Coll Cardiol. 2011;57(11):1314–22. DOI:10.1016/j.jacc.2011.01.011.; Wentzel J.J., Whelan D.M., van der Giessen W.J., van Beusekom H.M.M., Andhyiswara I., Serruys P.W., et al. Coronary stent implantation changes 3-D vessel geometry and 3-D shear stress distribution. J Biomech. 2000;33(10):1287-95. PMID: 10899339.; Samady H., Eshtehardi P., McDaniel M.C., Suo J., Dhawan S.S., Maynard C., et al. Coronary artery wall shear stress is associated with progression and transformation of atherosclerotic plaque and arterial remodeling in patients with coronary artery disease. Circulation. 2011;124(7):779-88. DOI:10.1161/CIRCULATIONAHA.111.021824.; Gyĭngyĭsi M., Yang P., Khorsand A., Glogar D. Longitudinal straightening effect of stents is an additional predictor for major adverse cardiac events. J Am Coll Cardiol. 2000;35(6):1580–9. DOI:. org/10.1016/S0735-1097(00)00570-2.; Nam D., Ni C.-W., Rezvan A., Suo J., Budzyn K., Llanos A., et al. Partial carotid ligation is a model of acutely induced disturbed flow, leading to rapid endothelial dysfunction and atherosclerosis. Am J Physiol Heart Circ Physiol. 2009;297(4):1535-43. DOI:10.1152/ajpheart.00510.2009.; Dudek D., Onuma Y., Ormiston J.A., Thuesen L., Miquel-Hebert K., Serruys P.W. Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: The ABSORB trial. EuroIntervention. 2012;7(9):1060-1. DOI:10.4244/ EIJV7I9A168.; Bourantas C.V., Papafaklis M.I., Garcia-Garcia H.M., Farooq V., Diletti R., Muramatsu T., et al. Short- and long-term implications of a bioresorbable vascular scaffold implantation on the local endothelial shear stress patterns. JACC Cardiovasc Interv. 2014;7(1):100– 1. DOI:10.1016/j.jcin.2013.01.139.; Waksman R. Biodegradable stents: they do their job and disappear. J Invasive Cardiol. 2006;18(2):70-4. PMID: 16446520.; Stack R.S,, Califf R.M,, Phillips H.R,, Pryor D.B,, Quigley P.J,, Bauman R.P., et al. Interventional cardiac catheterization at Duke Medical Center. Am J Cardiol. 1988;62(10, Pt 2):3F–24F. PMID: 2972185.; van der Giessen W.J., Slager C.J., van Beusekom H.M., van Ingen Schenau D.S., Huijts R.A., Schuurbiers J.C., et al. Development of a polymer endovascular prosthesis and its implantation in porcine arteries. J Interv Cardiol. 1992;5(3):175–85. PMID: 10150957.; van der Giessen W.J., Lincoff A.M., Schwartz R.S., van Beusekom H.M., Serruys P.W., Holmes D.R., et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation. 1996;94(7):16907. PMID: 8840862.; Tamai H., Igaki K., Kyo E., Kosuga K., Kawashima A., Matsui S., et al. Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans. Circulation. 2000;102(4):399-404. DOI:10.1161/01.CIR.102.4.399.; Nishio S., Kosuga K., Igaki K., Okada M., Kyo E., Tsuji T., et al. Long-term (>10 Years) clinical outcomes of first-in-human biodegradable polyl-lactic acid coronary stents: Igaki-Tamai stents. Circulation. 2012;125(19):2343–52. DOI:10.1161/CIRCULATIONAHA.110.000901.; Cook S., Ladich E., Nakazawa G., Eshtehardi P., Neidhart M., Vogel R., et al. Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drugeluting stent thrombosis. Circulation. 2009;120(5):391– 9. DOI:10.1161/CIRCULATIONAHA.109.854398.; Werner M., Micari A., Cioppa A., Vadalĭ G., Schmidt A., Sievert H., et al. Evaluation of the biodegradable peripheral Igaki-Tamai stent in the treatment of de novo lesions in the superficial femoral artery: The GAIA study. JACC Cardiovasc Interv. 2014;7(3):305-12. DOI:10.1016/j.jcin.2013.09.009.; Hildick-Smith D., Lassen J.F., Koo B.K. One or two stents for coronary bifurcation lesions? EuroIntervention. 2010;6(Suppl J(8):J61-4. DOI:10.1016/S0735-1097(00)00534-9.; Oberhauser J.P., Hossainy S., Rapoza R.J. Design principles and performance of bioresorbable polymeric vascular scaffolds. EuroIntervention. 2009;5(Suppl F):F15-22. DOI:10.4244/EIJV5IFA3.; Abizaid A., Ribamar Costa J., Bartorelli A.L., Whitbourn R., van Geuns R.J., Chevalier B., et al. The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled. EuroIntervention. 2015;10(12):1396-401. DOI:10.4244/EIJV10I12A243.; Jin Jang W., Hoon Yang J., Choi S.-H., Bin Song Y., Hahn J.-Y., Choi J.-H., et al. Fate of bioresorbable vascular scaffold metallic radio-opaque markers at the site of implantation after bioresorption. J Am Coll Cardiol Intv. 2015;8(8):271-9. DOI:10.1016/j.jcin.2015.04.010.; Serruys P.W., Onuma Y., Ormiston J.A., De Bruyne B., Regar E., Dudek D., et al. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: Six-month clinical and imaging outcomes. Circulation. 2010; 122(22):2301–12. DOI:10.1161/CIRCULATIONAHA.110.970772.; Serruys P.W., Onuma Y., Dudek D., Smits P.C., Koolen J., Chevalier B., et al. Evaluation of the second generation of a bioresorbable everolimuseluting vascular scaffold for the treatment of de Novo Coronary Artery stenosis: 12-month clinical and imaging outcomes. J Am Coll Cardiol. 2011;58(15):1578-88. DOI:10.1016/j.jacc.2011.05.050.; Gogas B.D., King S.B., Samady H. Bioresorbable polymeric scaffolds for coronary revascularization: Lessons learnt from ABSORB III, ABSORB China, and ABSORB Japan. Glob Cardiol Sci Pract. 2015;2015(5):62. DOI:10.5339/gcsp.2015.62.; Kereiakes D.J., Ellis S.G., Popma J.J., Fitzgerald P.J., Samady H., Jones-McMeans J., et al. Evaluation of a fully bioresorbable vascular scaffold in patients with coronary artery disease: Design of and rationale for the ABSORB III randomized trial. Am Heart J. 2015;170(4):641-651. DOI:10.1016/j.ahj.2015.07.013.; Kimura T., Kozuma K., Tanabe K., Nakamura S., Yamane M., Muramatsu T., et al. A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan. Eur Heart J. 2015;36(47):3332–42. DOI:10.1093/eurheartj/ehv435.; Testa L., Biondi Zoccai G., Tomai F., Ribichini F., Indolfi C., Tamburino C., et al. Italian Diffuse/ Multivessel Disease ABSORB Prospective Registry (ITDISAPPEARS). Study design and rationale. J Cardiovasc Med (Hagerstown). 2015;16(3):253–8. DOI:10.2459/ JCM.0000000000000219.; Simsek C., Karanasos A., Magro M., GarciaGarcia H.M., Onuma Y., Regar E., et al. Longterm invasive follow-up of the everolimus-eluting bioresorbable vascular scaffold: five-year results of multiple invasive imaging modalities. EuroIntervention. 2016;11(9):996-1003. DOI:10.4244/EIJY14M10_12.; Ruiz-Salmerĭn R.J., Pereira S., de Araujo D. Bioresorbable vascular scaffold collapse causes subacute thrombosis. J Invasive Cardiol. 2014;26(7):E98-9. PMID: 24993999.; Miyazaki T., Panoulas V.F., Sato K., Naganuma T., Latib A., Colombo A. Acute stent thrombosis of a bioresorbable vascular scaffold implanted for STsegment elevation myocardial infarction. Int J Cardiol. 2014;174(2):e72-74. DOI:10.1016/j.ijcard.2014.04.108.; Martĭn-Reyes R., Jimĭnez-Valero S., Navarro F., Moreno R. Subacute drug-eluting stent thrombosis caused by stent underexpansion: evaluation by optical coherence tomography. Case Rep Med. 2011;2011:1-3. DOI:10.1155/2011/129341.; Serruys P.W., Ormiston J.A., Onuma Y., Regar E., Gonzalo N., Garcia-Garcia H.M., et al. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet. 2009;373(9667):897–910. DOI:10.1016/S0140-6736(09)60325-1.; Ishibashi Y., Onuma Y., Muramatsu T., Nakatani S., Iqbal J., Garcia-Garcia H.M., et al. Lessons learned from acute and late scaffold failures in the ABSORB EXTEND trial. EuroIntervention. 2014;1–9. DOI:10.4244/EIJV10I4A78.; Kolandaivelu K., Swaminathan R., Gibson W.J., Kolachalama V.B., Nguyen-Ehrenreich K.L., Giddings V.L., et al. Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings. Circulation.2011;123(13):1400–9. DOI:10.1161/CIRCULATIONAHA.110.003210.; Papafaklis M.I., Bourantas C.V., Farooq V., Diletti R., Muramatsu T., Zhang Y., et al. In vivo assessment of the three-dimensional haemodynamic micro-environment following drug-eluting bioresorbable vascular scaffold implantation in a human coronary artery: Fusion of frequency domain optical coherence tomography and angiography. EuroIntervention. 2013;9(7):890. DOI:10.4244/EIJV9I7A147.; Farooq V., Serruys P.W., Heo J.H., Gogas B.D., Onuma Y., Perkins L.E., et al. Intracoronary optical coherence tomography and histology of overlapping everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: the potential implications for clinical practice. JACC Cardiovasc Interv. 2013;6(5):523-32. DOI:10.1016/j.jcin.2012.12.131.; Rzeszutko L., Depukat R., Dudek D. Biodegradable vascular scaffold ABSORB BVSTM - scientific evidence and methods of implantation. Adv Interv Cardiol. 2013;9(1):22–30. DOI:10.5114/ pwki.2013.34026.; Uren N.G., Schwarzacher S.P., Metz J.A., Lee D.P., Honda Y., Yeung A.C., et al. Predictors and outcomes of stent thrombosis: An intravascular ultrasound registry. Eur Heart J. 2002;23(2):124-32. DOI:10.1053/euhj.2001.2707.; Mattesini A., Pighi M., Konstantinidis N., Ghione M., Kilic D., Foin N., et al. Optical coherence tomography in bioabsorbable stents: mechanism of vascular response and guidance of stent implantation. Minerva Cardioangiol. 2014;62(1):71–82. PMID: 24500218.; Gomez-Lara J., Diletti R., Brugaletta S., Onuma Y., Farooq V., Thuesen L., et al. Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: An ABSORB cohort B trial sub-study. EuroIntervention. 2012;8(2):214–24. DOI:10.4244/EIJV8I2A35.; Nakamura S., Colombo A., Gaglione A., Almagor Y., Goldberg S.L., Maiello L., et.al. Intracoronary ultrasound observations during stent implantation. Circulation. 1994;89(5):2026–34. PMID: 8181126.; Ong D.S., Jang I.-K. Causes, assessment, and treatment of stent thrombosis-intravascular imaging insights. Nat Rev Cardiol. 2015;12(6):325-36. DOI:10.1038/nrcardio.2015.32.; Cheneau E., Leborgne L., Mintz G.S., Kotani J., Pichard A.D., Satler L.F., et al. Predictors of subacute stent thrombosis: results of a systematic intravascular ultrasound study. Circulation. 2003;108(1):43–7. DOI:10.1161/01.CIR.0000078636.71728.40.; Fitzgerald P.J., Oshima A., Hayase M., Metz J.A., Bailey S.R., Baim D.S., et al. Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study. Circulation. 2000;102(5):523–30. DOI:10.1161/01.CIR.102.5.523Circulation.; Casella G., Klauss V., Ottani F., Siebert U., Sangiorgio P., Bracchetti D. Impact of intravascular ultrasound-guided stenting on long-term clinical outcome: a meta-analysis of available studies comparing intravascular ultrasound-guided and angiographically guided stenting. Catheter Cardiovasc Interv. 2003;59(3):314–21. DOI:10.1002/ccd.10537.; Oemrawsingh P.V., Mintz G.S., Schalij M.J., Zwinderman A.H., Jukema J.W., van der Wall E.E. Intravascular ultrasound guidance improves angiographic and clinical outcome of stent implantation for long coronary artery stenoses: final results of a randomized comparison with angiographic guidance (TULIP Study). Circulation. 2003;107(1):62–7. PMID: 12515744.; Costa M.A., Angiolillo D.J., Tannenbaum M., Driesman M., Chu A., Patterson J., et al. Impact of stent deployment procedural factors on long-term effectiveness and safety of sirolimus-eluting stents (final results of the multicenter prospective STLLR trial). Am J Cardiol. 2008;101(12):1704-11. DOI:10.1016/j.amjcard.2008.02.053.; Cheneau E., Leborgne L., Mintz G.S., Kotani J., Pichard A.D., Satler L.F., et al. Predictors of subacute stent thrombosis: results of a systematic intravascular ultrasound study. Circulation. 2003;108(1):43-7. DOI:10.1161/01.CIR.0000078636.71728.40.; de Jaegere P., Mudra H., Figulla H., Almagor Y., Doucet S., Penn I., et al. Intravascular ultrasoundguided optimized stent deployment. Immediate and 6 months clinical and angiographic results from the Multicenter Ultrasound Stenting in Coronaries Study (MUSIC Study). Eur Heart J. 1998;19(8):1214-23. PMID: 9740343.; Takarada S., Imanishi T., Liu Y., Ikejima H., Tsujioka H., Kuroi A., et al. Advantage of nextgeneration frequency-domain optical coherence tomography compared with conventional time-domain system in the assessment of coronary lesion. Catheter Cardiovasc Interv. 2010;75(2):202–6. DOI:10.1002/ ccd.22273.; Fujino Y., Bezerra H.G., Attizzani G.F., Wang W., Yamamoto H., Chamiĭ D., et al. Frequency-domain optical coherence tomography assessment of unprotected left main coronary artery disease-a comparison with intravascular ultrasound. Catheter Cardiovasc Interv. 2013;82(3):E173-83. DOI:10.1002/ccd.24843.; Fujino Y., Attizzani G.F., Bezerra H.G., Wang W., Tahara S., Yamamoto H., et al. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography. JACC Cardiovasc Interv. 2013;6(10):103545. DOI:10.1016/j.jcin.2013.05.015.; Regar E., Schaar J.A., Mont E., Virmani R., Serruys P.W. Optical coherence tomography. Cardiovasc Radiat Med. 2003;4(4):198-204. DOI:10.1161/CIRCULATIONAHA.109.921528.; Finn A.V. Illuminating culprit plaque histology by optical coherence tomography: shedding new light on old insights. JACC Cardiovasc Interv. 2015;8(9):117779. DOI:10.1016/j.jcin.2015.05.002.; Gambichler T., Pljakic A., Schmitz L. Recent advances in clinical application of optical coherence tomography of human skin. Clin Cosmet Investig Dermatol. 2015;8:345–54. DOI:10.2147/CCID.S69119.; Gogas B.D., Radu M., Onuma Y., Perkins L., Powers J.C., Gomez-Lara J., et al. Evaluation with in vivo optical coherence tomography and histology of the vascular effects of the everolimus-eluting bioresorbable vascular scaffold at two years following implantation in a healthy porcine coronary artery model: implications of pilot resu. Int J Cardiovasc Imaging. 2012;28(3):499–511. DOI:10.1007/s10554011-9860-z.; Prati F., Di Vito L., Biondi-Zoccai G., Occhipinti M., La Manna A., Tamburino C., et al. Angiography alone versus angiography plus optical coherence tomography to guide decision-making during percutaneous coronary intervention: the Centro per la Lotta contro l’InfartoOptimisation of Percutaneous Coronary Intervention (CLI-OPCI) study. EuroIntervention. 2012;8(7):823–9. DOI:10.4244/EIJV8I7A125.; Allahwala U.K., Cockburn J.A., Shaw E., Figtree G.A., Hansen P.S., Bhindi R. Clinical utility of optical coherence tomography (OCT) in the optimisation of Absorb bioresorbable vascular scaffold deployment during percutaneous coronary intervention. EuroIntervention. 2015;10(10):1154-9. DOI:10.4244/EIJV10I10A190.; Asad A.A., Reddy K., Agarwala M.K., Dikshit B., Rath P.C., Purohit B.V., et al. Optical coherence tomography (OCT) guided deployment of ABSORB biovascular scaffolds in percutaneous coronary interventions. Indian Heart J. 2013;65:S89–90. DOI:10.4244/EIJV10I10A190.; https://www.surgonco.ru/jour/article/view/271Test

الإتاحة: https://doi.org/10.24060/2076-3093-2017-7-4-53-62Test
https://doi.org/10.24060/2076-3093-2017-7-4Test
https://doi.org/10.1161/CIRCINTERVENTIONS.109.859173Test
https://doi.org/10.1056/NEJM198703193161201Test
https://doi.org/10.1053/euhj.2001.2892Test
https://doi.org/10.1093/eurheartj/ehs102Test
https://doi.org/10.1016/j.jacc.2011.01.011Test
https://doi.org/10.1161/CIRCULATIONAHA.111.021824Test
https://doi.org/10.1016/S0735-1097Test(00)00570-2
https://doi.org/10.1152/ajpheart.00510.2009Test

المؤلفون: Albert Gilemkhanov, Shamil Safin, Khristina Derevyanko, Igor Buzaev, Ilmira Gilemkhanova

المصدر: British journal of neurosurgery. 33(6)

مصطلحات موضوعية: congenital, hereditary, and neonatal diseases and abnormalities, medicine.medical_specialty, Heart rhythm disorders, Drug Resistance, Neurosurgical Procedures, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Tachycardia, Female patient, medicine, Humans, Cyst, Foramen Magnum, business.industry, Headache, Cardiac arrhythmia, Congenital malformations, General Medicine, Middle Aged, medicine.disease, Decompression, Surgical, Magnetic Resonance Imaging, Syringomyelia, nervous system diseases, Arnold-Chiari Malformation, Heart Rhythm, 030220 oncology & carcinogenesis, embryonic structures, Cardiology, Surgery, Female, Neurology (clinical), Arnold chiari, business, 030217 neurology & neurosurgery

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b699e81b1ab5c27b24551b1857bf20eTest
https://pubmed.ncbi.nlm.nih.gov/31942819Test

المؤلفون: Sergey Chuykin, Elena Egorova, Guzel' Aflahanova, Natal'ya Makusheva, Igor' Buzaev, Galina Akat'eva

المصدر: Actual problems in dentistry. 14:47-51

مصطلحات موضوعية: Stenosis, medicine.medical_specialty, business.industry, Carotid arteries, Internal medicine, Dentine hypersensitivity, Cardiology, Medicine, In patient, business, medicine.disease

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::01ede32c032186428e9d5e5ce89104f8Test
https://doi.org/10.18481/2077-7566-2018-00009Test